← Eichor
Condition: Pemphigus Vulgaris Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Pemphigus Vulgaris

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Autoimmune Blistering Diseases Study
Phase N/A · 3 location(s) · University of Pennsylvania · NCT02753777Comparison of the Efficacy of Clobetasol Propionate 0.05% Mouthwash, Photobiomodulation, and Their Combination in Managi
NA · 1 location(s) · Damascus University · NCT07641725Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associate
Phase 1 · 1 location(s) · IRIS Research and Development, LLC · NCT06581562A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T
Phase 1/Phase 2 · 13 location(s) · Cabaletta Bio · NCT04422912Periodontal Status and Disease Severity in Pemphigus Vulgaris Patients
Phase N/A · 1 location(s) · Saglik Bilimleri Universitesi · NCT07384221CD19 CAR-T Therapy for Refractory Pemphigus Vulgaris
NA · 1 location(s) · Jinbo Chen · NCT07681388
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.